Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Lucy Scientific Discovery Inc LSDI

Lucy Scientific Discovery Inc. is an early stage psychotropics contract manufacturing company. The Company is engaged in researching, developing, and manufacturing psychotropic drugs. The Company is a manufacturer of controlled compounds dedicated to advancing the frontiers of mind science and facilitating the development of psychotropic and psychedelic treatment therapies. It is focused on developing therapies for patients in need, and through its lead candidate SANA-013, dedicated to advancing the understanding and applications of psychedelic medicine, improving mental health outcomes, and enhancing well-being for individuals worldwide. The Company is engaged in the production of a variety of natural, synthetic, and biosynthetic products to meet the needs of the psychotropics-based medicines market. Its products are in the form of raw materials, crude extracts, targeted formulations, single molecule fractions, and white- and private-label products.


NDAQ:LSDI - Post by User

Post by stockpsychoon May 10, 2023 12:31pm
46 Views
Post# 35440982

LUCY IS THE FUTURE

LUCY IS THE FUTURE

Neurological disorders are a major health concern worldwide.Lucy has shown great promise in the development of a new drug that could revolutionize the treatment of certain neurological disorders.

The drug, which is currently in the final stages of clinical trials, has shown remarkable efficacy in treating patients with Alzheimer's disease and other cognitive disorders. If approved by the FDA, it could potentially generate significant revenue for the company and drive a bullish performance in the coming years.

Investing in LUCY now could be a smart move, as the potential impact of this drug on the company's financials is significant. With a strong track record of success in the pharmaceutical industry, LUCY is poised to become a major player in the neurological drug market.

Those looking for a high-potential investment opportunity, LUCY is definitely worth keeping an eye on.

<< Previous
Bullboard Posts
Next >>